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Abstract: Cardiovascular disease (CVD) is the leading cause of death worldwide with mortality rates in
women currently exceeding those in men. To date, evidence is widely lacking for unique female determi-
nants of CVD. However, strong associations with psychological stress, obesity or elevated inflammatory
biomarkers with adverse cardiovascular outcomes in women have been identified in various studies. Inter-
estingly, amygdalar metabolic activity, a central neural structure involved in emotional stress processing,
has proven to be an independent predictor of major adverse cardiovascular events (MACE). Moreover,
upregulated amygdalar metabolism was directly linked to myocardial injury in women, but not in men.
This newly suggested sex-dependent brain-heart interrelation was further supported by the discovery
that bone marrow activity, a surrogate parameter of inflammation, represents a potential bridging link
between amygdalar activity and cardiovascular pathology by fueling inflammatory processes that promote
atherosclerotic disease. Such malignant cascade of events might account, at least in part, for the excess
female mortality seen in women with coronary artery disease and calls for sex-specific research toward
pharmacologic or behavioral modulators to improve cardiovascular outcomes, particularly in women.
This mini review summarizes recent advances in cardiovascular sex-specific medicine, thereby focusing
on the interplay between the limbic system, autonomic regulation and inflammatory biomarkers, which
may help to tailor CVD management toward the female cardiovascular phenotype.
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Cardiovascular disease (CVD) is the leading cause of death worldwide with mortality
rates in women currently exceeding those in men. To date, evidence is widely lacking for
unique female determinants of CVD. However, strong associations with psychological
stress, obesity or elevated inflammatory biomarkers with adverse cardiovascular
outcomes in women have been identified in various studies. Interestingly, amygdalar
metabolic activity, a central neural structure involved in emotional stress processing,
has proven to be an independent predictor of major adverse cardiovascular events
(MACE). Moreover, upregulated amygdalar metabolism was directly linked to myocardial
injury in women, but not in men. This newly suggested sex-dependent brain-heart
interrelation was further supported by the discovery that bone marrow activity, a
surrogate parameter of inflammation, represents a potential bridging link between
amygdalar activity and cardiovascular pathology by fueling inflammatory processes that
promote atherosclerotic disease. Such malignant cascade of events might account,
at least in part, for the excess female mortality seen in women with coronary
artery disease and calls for sex-specific research toward pharmacologic or behavioral
modulators to improve cardiovascular outcomes, particularly in women. This mini
review summarizes recent advances in cardiovascular sex-specific medicine, thereby
focusing on the interplay between the limbic system, autonomic regulation and
inflammatory biomarkers, which may help to tailor CVD management toward the female
cardiovascular phenotype.
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INTRODUCTION
While the term “sex” is used within the context of biological differences that constitute the
female and male characteristics of anatomy and physiology, the term “gender” typically refers
to the social and cultural differences between women and men (Wizemann and Pardue,
2001). Indeed, a plethora of studies have consistently reported sex and gender differences
in various pathologies (Miller, 2014). As such, initial efforts have been made to personalize
medicine toward sex- and gender-specific differences, yet, much remains to be elucidated to
identify reliable determinants that can be incorporated into current risk stratification and
clinical guidelines.
Sex and gender differences play amajor role for the diagnosis andmanagement of cardiovascular
disease (CVD). Indeed, CVD mortality rates in women in Europe have surpassed those in men
(Shaw et al., 2009; Wilmot et al., 2015; Townsend et al., 2016). Women develop CVD with similar
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frequency as men do, but on average 10 years later in life
(Garcia et al., 2016). Once women experience an acute coronary
syndrome (ACS), however, their prognosis is worse than that of
men, even when adjusting for age differences (Haider et al., 2020).
Notably, mortality rates of ACS in women below 55 years of age
are currently increasing, while fatality decreased in age-matched
men (Gabet et al., 2017; Arora et al., 2019). Althoughmechanisms
behind the increasing cardiovascular vulnerability of women
are not yet understood, there is a growing body of evidence
for sex and gender differences in cardiovascular risk factors,
treatment efficacy, and cardiovascular outcomes (Pagidipati and
Peterson, 2016; Vaccarino, 2019). As such, epicardial coronary
arteries are smaller in women than in men, independent of
adjustment for body mass index, left ventricular dimensions and
age (Hiteshi et al., 2014). Further, parameters of myocardial blood
flow (MBF), as determined by positron emission tomography,
such as baseline and hyperemic MBF are higher in women
than in men, thus leading to a comparable global coronary
flow reserve in women and men (Murthy et al., 2014; Haider
et al., 2019a). The smaller diameter of epicardial coronary
arteries and higher baseline MBF in women is proposed to result
in higher endothelial shear stress in female coronaries (Patel
et al., 2016). As low endothelial shear stress predisposes for
regional lipid accumulation, pathologic plaque remodeling, and
atherosclerotic plaque instability (Koskinas et al., 2013), it is
suggested that the condition of increased shear stress in women’s
coronary arteries could explain sex disparities in coronary artery
disease (CAD) susceptibility (Kerkhof and Miller, 2018). The
traditional focus of cardiovascular research on the identification
and treatment of epicardial obstructive CAD, a condition more
frequently observed in males than in females, and the detection
of the “vulnerable” atherosclerotic plaque as the primary cause
of ischemic injury might further explain the decreasing mortality
rates in men, but not in women (Arbab-Zadeh and Fuster,
2015; Haider et al., 2020). Women tend to display a more
diffuse and non-obstructive coronary artery disease pattern
with distinct plaque characteristics such as lower overall plaque
burden, coronary calcium content, and less necrosis in the
core of the plaque (Lansky et al., 2012). In the absence of
obstructive CAD, coronary microvascular dysfunction (CMVD)
has been associated with an increased frequency of hypertrophic
cardiomyopathy and thus, the development of adverse cardiac
events such as heart failure, arrythmias, and sudden cardiac
death (Crea et al., 2014). Of note, CMVD is more frequently
observed in women than in men (Dean et al., 2015). Further,
CMVD is associated with sympathetic hyperactivity, which in
turn contributes to a reduced event-free survival in women, but
not in men (Gebhard et al., 2019; Maredziak et al., 2020). In
addition, elevated baseline levels of inflammatory biomarkers and
a more pronounced inflammatory response to emotional stress-
induced myocardial ischemia have both been observed primarily
in women (Sullivan et al., 2018). An overview of the potential
involvement of the heart-brain axis in sex-dependent risk factors
and presentations of CVD is provided in Figure 1.
In this mini review, we aim to highlight neurohumoral
sex differences that have been recently linked to CVD. As
such, this review focuses on the interplay between the limbic
system, autonomic dysregulation and inflammation within
the context of CVD.
AMYGDALAR ACTIVITY AND THE
FEMALE HEART
The female propensity toward worse outcomes has prompted
a call to reconsider current and traditional risk-stratification
methods in cardiovascular medicine (Bairey Merz et al., 2017).
In particular, concerns have been raised about the excess
female vulnerability toward non-traditional risk factors such
as unrecognized psychosocial factors, sex-specific neural, and
vascular stress responses. Recent investigations demonstrate
a higher burden of emotional stress following an ACS and
a predominant occurrence of Takotsubo cardiomyopathy in
women (Vaccarino and Bremner, 2017; Vaccarino et al.,
2018) suggesting a sex-specific neuro-cardiac link. Takotsubo
cardiomyopathy leads to transient left ventricular dysfunction
as a result from severe psychological stress. Moreover, impaired
connectivity of brain structures involved in the control of the
autonomous nervous system has been detected in patients with
Takotsubo cardiomyopathy (Templin et al., 2019). Although
Takotsubo cardiomyopathy is responsible for only 3% of ACS
cases, the prevalence in postmenopausal women is twice as
high (Ghadri et al., 2018). An important role in processing
higher brain functions such as cognition and emotion is
attributed to the brain’s ventral-attention or salience network
(Sevinc et al., 2017). It is primarily composed of the anterior
insula and the dorsal anterior cingulate cortex. Independent
component analysis using functional magnet resonance imaging
identified further associated structures including the amygdala,
a central structure of the limbic system (Wang et al., 2010).
Of note, efferent projections of the amygdala to the brain
stem were found to be engaged in the sympathetic stress
response (LeDoux et al., 1988). A recent study concluded that
amygdalar metabolic activity is an independent risk predictor
for major adverse (MACE) over and above conventional
cardiovascular risk factors (Tawakol et al., 2017). As a potential
mechanism, an increased inflammatory state as witnessed by
upregulated bone marrow activity and arterial inflammation
has been suggested. This hypothesis is further supported by
the observation that increased inflammation enhanced cardiac
remodeling via upregulation of interleukin-18 and myocardial
β-adrenergic receptor hyper-activation in an experimental model
(Xiao et al., 2018).
A recent study focusing on myocardial function, perfusion,
and metabolic amygdalar activity revealed an association
between elevated amygdalar activity and impaired myocardial
perfusion/function. Notably, these associations were observed
in women, but not in men (Fiechter et al., 2019a). Further,
resting amygdalar activity was not affected by high coronary
artery calcium scoring, suggesting that the extend of myocardial
injury, rather than atherosclerotic plaque burden, is mainly
responsible for an enhanced neural stress response in the female
population. Together with the findings provided by Tawakol
et al. (2017), this investigation strengthens the hypothesis that a
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FIGURE 1 | Potential involvement of the heart-brain axis in sex-dependent risk factors and presentations of cardiovascular disease (CVD). BMI, body mass index;
CAD, coronary artery disease; CMVD, coronary microvascular dysfunction; CRP, C-reactive protein; MACE, major adverse cardiac events; ACS, acute coronary
syndromes; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
disproportionate burden of emotional stress might contribute to
worse cardiovascular outcomes in women with ACS.
Finally, Mehta et al. (2019) proposed a malignant cascade
that interconnects the limbic system via the hypothalamus to
neurohormonal systems (cortisol and norepinephrine), which
in turn upregulates heart rate and blood pressure. This may
ultimately lead to the activation of inflammatory processes,
endothelial dysfunction, and atherosclerosis, thereby increasing
the risk of ACS, heart failure, and sudden cardiac death.
ALTERED AUTONOMOUS NERVOUS
SYSTEM ACTIVITY AND UPREGULATED
INFLAMMATORY STATE: THE MISSING
PIECE OF THE PUZZLE?
An enhanced sympathetic tone has recurrently been observed
in women with CMVD, Takotsubo cardiomyopathy (Di Monaco
et al., 2010; Templin et al., 2015), and ACS (Ubrich et al.,
2017), and was associated with adverse cardiovascular outcomes
(Hogarth et al., 2009). Similarly, worse prognoses have been
documented in women with heart failure and myocardial
infarction and were found to be related to upregulated
cardiac sympathetic activity (La Rovere et al., 1998; Mitoff
et al., 2011). Of note, sympathetic activity remained elevated
until 9 month after an ACS in women, adding to an
unfavorable prognosis (Hogarth et al., 2009). Cardiac autonomic
dysregulation in women with major depressive disorder and
negative affective stimuli has recently been shown to be associated
with hypoconnectivity between the hippocampus, amygdala,
right orbitofrontal cortex, and the hypothalamus (Garcia et al.,
2020). In the same subpopulation hyperactivity of the right
amygdala and the hypothalamus was observed, suggesting
that cardiac autonomic dysregulation is linked to emotional
stress in women.
Activation of inflammatory processes affects cardiovascular
outcomes in both, stable and unstable angina, irrespective of
myocardial damage and conventional risk markers of CVD (de
Lemos et al., 2003; Gebhard et al., 2017; Kalkman et al., 2018).
Similarly, levels of inflammatory biomarkers have been shown
to be sex- and ethnicity-dependent (Khera et al., 2005) with
distinct upregulation of inflammatory cells, C-reactive protein
(CRP) and interleukin-6 (Thorand et al., 2006). Moreover,
the recent CANTOS trial, which assessed the safety and
efficacy of the anti-inflammatory drug Canakinumab in patients
with previous myocardial infarction, reported a significantly
reduced event rate in the test group, as compared to the
placebo arm (Ridker et al., 2017). In a secondary analysis
from the CANTOS trial, the authors unveiled that women
and men both benefited from canakinumab treatment, as
shown by the composite cardiovascular endpoint encompassing
recurrent non-fatal myocardial infarction, non-fatal stroke,
cardiovascular death and unstable angina (Ridker et al., 2018).
However, the use of anti-inflammatory therapy is still far
from application in cardiovascular clinical routine. This is
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reflected by the inefficacy of methotrexate to treat stable
CAD (Ridker et al., 2019). In addition, colchicine has lately
been observed to reduce the risk of ischemic cardiovascular
events in patients with recent myocardial infarction (Nidorf
et al., 2020). Notably, this risk reduction was non-significant
in women, as demonstrated by a subgroup analysis. Further,
no sex-disaggregated data on adverse effects of colchicine were
reported. This is a major omission given that experimental
studies in rats indicate a twofold higher susceptibility to lethal
effects of colchicine in females (Wiesenfeld et al., 2007). While
cardiovascular pathologies and outcomes have been associated
with a higher level of inflammatory activity, it was only recently
demonstrated that an upregulated metabolic activity of the
vertebral bone marrow, a surrogate marker of inflammation,
is a strong and independent predictor of myocardial injury,
suggesting that inflammatory biomarkers play a significant
role in the development and progression of CAD toward
myocardial ischemia and fibrosis (Fiechter et al., 2019a). Most
intriguingly, these observations were sex-dependent with a
significant association of inflammation and myocardial function
and perfusion in women, but not in men.
In summary, a sex-specific mechanism linking cardiovascular
pathologies with inflammation is so far lacking. Nonetheless,
experimental findings suggest a distinct association between
sympathetic hyperactivity, upregulation of cytokine cascades,
and pathological myocardial remodeling (Xiao et al., 2018).
Potential underlying mechanisms may include the toxicity of
NLRP3 inflammasome complexes on myocardial cells, which are
triggered by sympathetic hyperactivity (Karakas et al., 2018).
Further, an elevated body mass index and other CVD risk
factors are tightly associated with higher inflammatory states
mainly reflected by higher CRP levels in the female, but not
in the male population (Wong et al., 2001; Qasim et al.,
2011; Pruijm et al., 2013; Shanahan et al., 2014). Finally,
adjustment for CRP leads to a loss of a positive association
between atherosclerotic plaque eccentricity and epicardial fat in
women. This link further points toward a detrimental association
between inflammation and adipose tissue in women (Miao et al.,
2011; Haider et al., 2019b). In conclusion, there is an unmet
medical need for tailored preventive strategies in women to
assess their residual inflammation-related cardiovascular risk
(Gencer and Mach, 2019).
FIGURE 2 | Hypothetic mechanisms of the neuro-inflammatory-vascular circuit. (1) Activity in the brain’s salient network is induced by acute stress (orange arrow)
and chronic stress (red arrow), thereby triggering the activation of the amygdala. (2) Efferent projections to the brainstem upregulate sympathetic activity as well as
the hypothalamic-pituitary-adrenal axis leading to an increase in circulating norepinephrine and cortisol. In an acute setting this results in an increased heart rate and
blood pressure, which can be pharmacologically targeted by sympatholytic agents. In a chronic state, the tonic firing of the amygdala leads to modulation of central
brain structures, such as the locus coeruleus, and to a chronic inflammatory state. (3) This is reflected by enhanced bone marrow activity and release of progenitor
inflammatory cells. (4) Inflammatory cytokines (interleukin-6 and interleukin-18) promote endothelial dysfunction and progression of atherosclerosis. (5) The latter
increases the risk of adverse cardiac events. Targeted anti-inflammatory treatment or behavioral strategies (e.g., stress reduction concepts) have the potential to
diminish detrimental effects on the cardiovascular system.
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THE NEURO-INFLAMMATORY-
VASCULAR CIRCUIT: EVIDENCE FOR A
SEX-SPECIFIC LINK?
Currently, deleterious sex-specific effects of enhanced
psychological stress on cardiovascular health are largely
unexplored. However, in an experimental mouse model,
Xiao et al. (2018) linked fibrotic myocardial remodeling to
myocardial sympathetic hyperactivity, with the latter prompting
inflammasome-dependent release of interleukin-18. This
observation supports a strong relation between activation of the
autonomous nervous system, inflammatory state, and adverse
cardiovascular outcomes. Moreover, a recent investigation on
the association between central neural structures, inflammation,
and myocardial injury revealed for the first time a sex-specific
link between enhanced resting amygdalar metabolic activity,
upregulated inflammatory state, reflected by heightened bone
marrow activity, and myocardial function, i.e., presence of
myocardial scar and left ventricular dysfunction (Figure 2;
Fiechter et al., 2019b). These findings add to the body of evidence
concerning the concept of sexual dimorphism in emotional stress
responses, mediated by the limbic system.
A hypothesis with regard to the potential mechanism
interconnecting the brain with the heart has recently been
suggested by Mehta et al. (2019). The authors proposed a
malignant cascade of events following a stress trigger consisting
of interconnected areas of the brain such as the prefrontal cortex,
the amygdala, the hippocampus, and the locus coeruleus. In
detail, psychological stress stimulated the amygdala, which in
turn activated the hypothalamus-pituitary-adrenal axis by the
sympathetic nervous system and its sites of control, i.e., nucleus
tractus solitarius, the parabrachial nucleus, the rostroventral
lateral medulla, and the dorsal motor nucleus of the vagal nerve
(Vaccarino and Bremner, 2017; Bremner et al., 2018). This
activation may then result in increased levels of epinephrine,
norepinephrine, and cortisol leading to an activation of the body’s
“fight and flight” system such as an upregulated heart rate and
blood pressure (Vaccarino and Bremner, 2017). During states
of chronic stress exposure, executive functions of the medial
prefrontal cortex are tuned down, while amygdalar activity is
enhanced and thus, continuous activation of the noradrenergic
locus coeruleus was observed (Arnsten et al., 2015). This
persistent amygdalar firing may lead to chronic sympathetic
hyperactivity, prompting an upregulated inflammatory state as
well as subsequent endothelial dysfunction and atherosclerosis
(Lima et al., 2019).
CONCLUSION
Notwithstanding the substantial progress that has been made
in CVD management, current reports still point to a persistent
knowledge gap concerning optimized management and risk-
stratification in women, particularly with regard to ACS. One of
the major challenges to close this gap is to reduce the persistent
underrepresentation of females in cardiovascular clinical trials
(Scott et al., 2018). Further, the neuro-inflammatory-vascular
circuit appears to contribute disproportionally to cardiovascular
risk in women and men. Specifically, emotional stress-induced
amygdalar activity leading to upregulated inflammatory
pathways, negatively affects the heart’s function and perfusion
in the female, but not in the male population. This mechanism
might further contribute to the development of Takotsubo
cardiomyopathy, thereby explaining the predominance of
women in Takotsubo cardiomyopathy. Finally, there is a plethora
of unanswered questions concerning the impact of socio-
environmental and contextual factors on gender-associated
manifestation of ACS presentation and outcomes. Thus, further
work is needed to identify interrelating molecular pathways of
this cascade with the ultimate aim to develop pharmacologic and
behavioral therapies that are tailored to women and men.
FUTURE PERSPECTIVES
Despite the fundamental knowledge gaps that currently exist
in our understanding of the mechanisms underlying brain-
heart interactions in CVD patients, there is a growing interest
to dissect the pathways involved. As such, initial efforts
have been undertaken to understand the role of enhanced
baseline inflammation and sympathetic hyperactivity in patients
with adverse cardiovascular outcomes. Although an enhanced
amygdalar metabolic activity has been linked to adverse
cardiovascular events, interventional studies are required to
establish a direct causality. Further, to dissect underlying
molecular mechanisms, it is imperative to address pivotal
questions including, but not limited to; (1) What are the key
components of the immune system that are affected by amygdalar
activation? (2) Does amygdalar activation result in impaired
cardiac function and/or abnormal cardiac perfusion by triggering
sympathetic hyperactivity? (3)Why are women disproportionally
affected by emotional stress and what is the role of sex hormones
in governing brain-heart interactions? (4) In addition to the
prognostic value of enhanced amygdalar metabolic activity, can
the “amygdala-related” cardiovascular risk be modulated by
therapeutic intervention? Translational molecular imaging has so
far played a critical role in elucidating complex interactions of
the brain-heart axis. Nonetheless, a multidisciplinary effort will
be required to address the abovementioned questions. Further,
prospective studies are warranted to translate these intriguing
concepts into a genuine advantage for CVD patients.
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